JavaScript is disabled.
Some features may not work properly. For the best experience, please enable JavaScript in your browser.
Ledgeburg
Sign In
Loading...
News
Latest
Latest News
Stocks
Discover
Search Stocks
ETFs
Discover
Search ETFs
Funds
Discover
Search Funds
SYRE Financials - Spyre Therapeutics Income & Cash Flow | Ledgeburg
SYRE - Spyre Therapeutics, Inc.
USD | NASDAQ | Healthcare
Summary
Summary SYRE Stock
Financials
Financials SYRE Stock
Loading...
Loading...
Income Statement
Income Statement SYRE Stock
Balance Sheet
Balance Sheet SYRE Stock
Cash Flow Statement
Cash Flow Statement SYRE Stock
Loading...
Loading...
Home
Stocks
Spyre Therapeutics, Inc. (SYRE)
Financials
Financials of SYRE
Loading...
Loading...
Loading...
Loading...
Revenue
$0
Operating Income
$-209.562M
Net Income
$-155.203M
Share Count (Basic)
N/A
Operating Cash Flow
$-169.252M
Free Cash Flow
N/A
Cash And Short-Term Equivalents
$85.721M
Total Debt
N/A
Annual
Quarterly
Revenue $USD
0
5M
10M
15M
20M
FY2021
FY2022
FY2023
FY2024
FY2025
Revenue $USD
No data available
Annual
Quarterly
Net Income $USD
-300M
-250M
-200M
-150M
-100M
Annual
Quarterly
Margins
Gross
Operating
Net
-40000%
-30000%
-20000%
-10000%
0%
FY2021
FY2022
FY2023
FY2024
FY2025
Net Income $USD
-60M
-40M
-20M
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26
FY2021
FY2022
FY2023
FY2024
FY2025
Margins
No data available